X0306 4 2021-09-03 false 0001636422 Health Catalyst, Inc. HCAT 0001780980 Burton Daniel D. C/O HEALTH CATALYST, INC. 10897 SOUTH RIVER FRONT PARKWAY, #300 SOUTH JORDAN UT 84095 true true false false Chief Executive Officer Common Stock 2021-09-03 4 M false 48437.00 10.80 A 299789.00 D Common Stock 2021-09-03 4 M false 9493.00 15.84 A 309282.00 D Common Stock 2021-09-03 4 S false 52730.00 54.3205 D 256552.00 D Common Stock 2021-09-03 4 S false 5200.00 54.5978 D 251352.00 D Common Stock 2021-09-07 4 S false 15890.00 54.903 D 235462.00 D Common Stock 2021-09-07 4 M false 10819.00 15.84 A 246281.00 D Stock Option (Right to Buy) 15.84 2021-09-03 4 M false 9493.00 0.00 D 2029-02-05 Common Stock 9493.00 120065.00 D Stock Option (Right to Buy) 10.80 2021-09-03 4 M false 48437.00 0.00 D 2028-09-27 Common Stock 48437.00 206180.00 D Stock Option (Right to Buy) 15.84 2021-09-07 4 M false 10819.00 0.00 D 2029-02-05 Common Stock 10819.00 109246.00 D The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 4, 2021, in accordance with Rule 10b5-1. Represents the weighted average sale price of the shares sold ranging from $53.54 to $54.53 per share, inclusive. Represents the weighted average sale price of the shares sold ranging from $54.54 to $54.72 per share, inclusive. Represents the weighted average sale price of the shares sold ranging from $54.63 to $55.38 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) through (4). 25% of the 299,748 shares underlying the option vested in an annual installment on February 5, 2020 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on February 5, 2023. 25% of the 747,223 shares underlying the option vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022. /s/ Daniel Orenstein, as Attorney-in-Fact 2021-09-08